Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

SAN

Banco Santander (SAN)

Banco Santander SA
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:SAN
DatumZeitQuelleÜberschriftSymbolFirma
23/12/202413h49Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:SANBanco Santander SA
19/12/202403h30Business WireSantander Bank Lowers Its Prime Rate to 7.50%NYSE:SANBanco Santander SA
10/12/202419h51Business WireSantander Goes National in the United States with Openbank, Bringing High Yield Savings Opportunities to More AmericansNYSE:SANBanco Santander SA
29/11/202412h27Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:SANBanco Santander SA
21/11/202412h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:SANBanco Santander SA
19/11/202419h43Business WireMisperceptions Preventing Americans From Earning More on Their Money Ahead of Holiday Season, Santander Survey FindsNYSE:SANBanco Santander SA
14/11/202412h19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:SANBanco Santander SA
07/11/202422h05Business WireSantander Bank Lowers Its Prime Rate to 7.75%NYSE:SANBanco Santander SA
30/10/202411h37IH Market NewsUS Futures Rise as Tech Earnings Drive Market Optimism; Oil Prices Edge UpNYSE:SANBanco Santander SA
29/10/202412h21Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:SANBanco Santander SA
29/10/202412h16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:SANBanco Santander SA
29/10/202412h11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:SANBanco Santander SA
29/10/202412h04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:SANBanco Santander SA
29/10/202410h39IH Market NewsHSBC Reports $8.5 Billion Profit; Boot Barn Announces New CEO and Projections; TMDX Drops 24%, VFC Surges 22%NYSE:SANBanco Santander SA
25/10/202412h05IH Market NewsCapri Shares Crash 45% After Merger Block; Coursera Falls 18% on Lower Revenue ForecastNYSE:SANBanco Santander SA
17/10/202412h12Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:SANBanco Santander SA
17/10/202408h35Business WireSanofi and Orano Join Forces to Develop Next-generation Radioligand MedicinesNYSE:SANBanco Santander SA
17/10/202408h35Business WireSanofi et Orano Med unissent leurs forces pour développer des radiothérapies internes vectorisées de nouvelle générationNYSE:SANBanco Santander SA
16/10/202412h02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:SANBanco Santander SA
08/10/202416h09Business WireMiddle-Income Consumers Remain Confident Amidst Price Pressures, Santander US Survey FindsNYSE:SANBanco Santander SA
24/09/202415h18Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:SANBanco Santander SA
23/09/202412h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:SANBanco Santander SA
18/09/202422h39Business WireSantander Bank Lowers Its Prime Rate to 8.00%NYSE:SANBanco Santander SA
16/09/202416h33Business WireSantander Bank Earns “Outstanding” Community Reinvestment Act Rating by the OCCNYSE:SANBanco Santander SA
12/09/202412h02IH Market NewsNorfolk Southern CEO Fired, Ryanair Lowers Fare Forecast, 23andMe Considers Acquisition ProposalsNYSE:SANBanco Santander SA
12/09/202408h37Business WireSanofi, RadioMedix, and Orano Med Announce Licensing Agreement on Next-Generation Radioligand Medicine for Rare CancersNYSE:SANBanco Santander SA
12/09/202408h37Business WireAccord de licence entre Sanofi, RadioMedix et Orano Med pour le développement d’une nouvelle génération de radiothérapies internes vectorisées contre les cancers raresNYSE:SANBanco Santander SA
11/09/202412h25IH Market NewsGameStop plunges 11% on stock offering, DJT drops post-debate, GSK fails shingles vaccine trialNYSE:SANBanco Santander SA
05/09/202412h13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:SANBanco Santander SA
03/09/202418h19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:SANBanco Santander SA
 Showing the most relevant articles for your search:NYSE:SAN